The iris after prostanoid treatment

被引:20
作者
Grierson, Ian [1 ]
Cracknell, Kathryn P. B. [1 ]
Pfeiffer, Norbert [2 ]
机构
[1] Univ Liverpool, Dept Med, Unit Ophthalmol, Liverpool L3 9PF, Merseyside, England
[2] Johannes Gutenberg Univ Mainz, Dept Ophthalmol, D-55122 Mainz, Germany
关键词
D O I
10.1097/00055735-200104000-00006
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Morphologic studies to date show that prostanoid-induced iris color change is not associated with any major pathologic process in the tissue. There is no evidence of melanocyte proliferation. The most likely mechanism for iris color darkening is increased melanogenesis, but this is not so marked as to cause any extensive release of melanin granules that might cause iris inflammation or even a pigmentary-type of glaucoma. Some patients, but not all, with color darkening have an apparent thickening of the anterior border zone; it remains to be established whether this is true thickening or merely if the anterior border is emphasized because of increased pigmentation. (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:112 / 118
页数:7
相关论文
共 34 条
[11]  
Freddo TF, 1996, MICROSC RES TECHNIQ, V33, P369, DOI 10.1002/(SICI)1097-0029(19960401)33:5<369::AID-JEMT1>3.0.CO
[12]  
2-J
[13]  
GOODALL T, 1994, INVEST OPHTH VIS SCI, V35, P826
[14]   The fine structure of an iridectomy specimen from a patient with latanoprost-induced eye color change [J].
Grierson, I ;
Lee, WR ;
Albert, DM .
ARCHIVES OF OPHTHALMOLOGY, 1999, 117 (03) :394-396
[15]  
Grierson I, 1998, PROSTAGLANDINS OPHTH, P105
[16]  
Hadley ME, 1966, ADV BIOL SKIN, V8, P379
[17]   Effect of prostaglandins A2, E1, F2α and latanoprost on cultured human iridal melanocytes [J].
Hu, DN ;
Stjernschantz, J ;
McCormick, SA .
EXPERIMENTAL EYE RESEARCH, 2000, 70 (01) :113-120
[18]  
HU DN, 1995, INVEST OPHTH VIS SCI, V36, P931
[19]   Influence of autonomic neurotransmitters on human uveal melanocytes in vitro [J].
Hu, DN ;
Woodward, DF ;
McCormick, SA .
EXPERIMENTAL EYE RESEARCH, 2000, 71 (03) :217-224
[20]  
HU DN, 1992, INVEST OPHTH VIS SCI, V33, P2443